Balaxi Pharmaceuticals Ltd.
Snapshot View

438.30 +12.30 ▲2.9%

12 August 2022, 03:58:52 PM
Volume: 2,327

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.balaxipharma.in
Market Cap 438.30 Cr.
Enterprise Value(EV) 434.75 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 51.09 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 8.58 Trailing Twelve Months Ending 2022-06
Industry PE 32.02 Trailing Twelve Months Ending 2022-06
Book Value / Share 127.31 Trailing Twelve Months Ending 2022-06
Price to Book Value 3.44 Calculated using Price: 438.30
Dividend Yield 0.11 Period Ending 2022-03
No. of Shares Subscribed 1.00 Cr. 10,000,000 Shares
FaceValue 10
Company Profile
The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG products

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.89%
1 Week
+2.33%
1 Month
+14.78%
3 Month
+7.68%
6 Month
-1.48%
1 Year
-22.79%
2 Year
+20.30%
5 Year
+1339.41%
10 Year
4 years 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 55.84 39.04 82.26 53.50
Return on Capital Employed (%) 69.35 56.56 92.56 59.62
Return on Assets (%) 32.19 29.01 56.23 34.52

Balance Sheet View Details >>

Particulars 4 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 4 28 65 113
Non Curr. Liab. 0 0
Curr. Liab. 3 8 35 63
Minority Int.
Equity & Liab. 6 36 100 176
Non Curr. Assets 0 1 6 35
Curr. Assets 6 35 94 141
Misc. Exp. not W/O
Total Assets 6 36 100 176

Profit Loss View Details >>

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 14 46 231 279 304
Other Income 1 1 2 5 7
Total Income 14 46 234 284 311
Total Expenditure -12 -37 -189 -229 -251
PBIDT 2 9 45 56 60
Interest 0 0 -1 0
Depreciation 0 0 -1 -1
Taxation 0 -3 -6 -7 -8
Exceptional Items
PAT 2 6 38 48 51
Minority Interest
Share Associate
Other Related Items -1 1
Consolidated Net Profit 2 6 37 48 51
Adjusted EPS 6 6 37 48 51

Cash Flow View Details >>

Particulars 4 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -2 -14 34
Cash Fr. Inv. 0 0 -6 -28
Cash Fr. Finan. 18 4 0
Net Change -2 4 -2 6
Cash & Cash Eqvt 0 4 2 7

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 72.86 72.86 72.86 72.86 72.86 72.86 72.86 72.86 72.86
Public 27.14 27.15 27.13 27.14 27.14 27.13 27.14 27.14 27.14
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 10 Aug 2022
Schedule of Analysts/Institutional Investor Meet/Con. Call
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call
Fri, 05 Aug 2022
Schedule of Analysts/Institutional Investor Meet/Con. Call
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call
Thu, 04 Aug 2022
Schedule of Analysts/Institutional Investor Meet/Con. Call
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call

Technical Scans View Details >>

Fri, 12 Aug 2022
Close Crossing Last Month High Close Crossing Last Month High
Closing Above Previous High Closing Above Previous High
Making Lower Lows for 3 days Making Lower Lows for 3 days
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index
High Increase 1 Month High Increase 1 Month

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 219,167.25 913.45 -0.8%
Divi's Laboratories Ltd. 98,918.90 3,726.20 -5.6%
Cipla Ltd. 82,906.37 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. 70,920.35 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. 62,010.73 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. 51,917.53 1,534.00 -0.1%
Piramal Enterprises Ltd. 45,855.65 1,921.35 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.35 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 33.43 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 33.32 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.69 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 70.15 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.82 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 24.38 1,921.35 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.37 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8.44 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-06 3.86 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.50 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.43 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.12 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-06 1.28 1,921.35 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1.56 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 3.87 1,921.35 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 13,993.30 1,921.35 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 913.45 -0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,726.20 -5.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,027.35 -1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,260.80 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,312.75 -2.6%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,534.00 -0.1%
Piramal Enterprises Ltd. Consolidated 2022-03 1,345.89 1,921.35 +0.8%

FAQ's On Balaxi Pharmaceuticals Ltd.

Can I Buy Balaxi Pharma. Shares now?

What is the Share Price of Balaxi Pharma.?

What is the Relative Strength Index (RSI) Value of Balaxi Pharma.?

What is the Market Capital (MCAP) of Balaxi Pharma.?

What are the key metrics to analyse Balaxi Pharma.?

What is the Price Performance of Balaxi Pharma.?